XLON
CTPE
Market cap434mUSD
Oct 09, Last price
468.00GBP
Name
CT Private Equity Trust PLC
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CT Private Equity Trust PLC deploys capital across three primary strategies: indirect secondary investments, direct investments, and allocations to other private equity funds. Within its fund-of-funds approach, the trust targets a diverse range of vehicles including private equity, offshore, buy-out, venture, mezzanine, and investment trusts. For its direct investment activities, the fund spans various stages such as mezzanine financing, early-stage, mid-stage, and late-stage venture capital, middle-market, later-stage, mature, and buyout transactions. The trust maintains strict portfolio limits at the point of investment: no more than 15% of its total assets may be invested in UK-listed investment companies, with the same 15% ceiling for non-UK listed investment companies. Direct private equity co-investments are capped at 33% of total assets. Furthermore, investments outside the United States, United Kingdom, and Continental Europe are restricted to a maximum of 10% of total assets. While pursuing a global investment mandate, the fund demonstrates a notable inclination towards the mid-market segment in the United Kingdom and Europe. Its investment focus is predominantly on mid-capitalization companies, and it also allocates capital to emerging markets.
Key people
Douglas Kinloch Anderson
Non-Executive Independent Director · since 2000
Elizabeth Anita Kennedy
Non-Executive Independent Director · since 2007
John Rafferty
Non-Executive Independent Director · since 2000
David R. Shaw
Non-Executive Independent Director · since 2009
IPO date
Mar 22, 1999
Employees
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
6TH FLOOR QUARTERMILE 4, 7A NIGHTINGALE WAY
Edinburgh, EDH EH3 9EG
GB
Edinburgh, EDH EH3 9EG
GB
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||